Kiora Pharmaceuticals (KPRX) Other Non Operating Income (2014 - 2026)

Kiora Pharmaceuticals (KPRX) has reported Other Non Operating Income for 8 consecutive years, with -$11471.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income rose 87.74% year-over-year to -$11471.0; the trailing twelve-month figure through Jun 2026 stood at -$109061.0 (down 49.52% YoY), and the FY2025 full-year result was -$160272.0, down 714.7% from the prior year.
• Other Non Operating Income grew to -$11471.0 in Q2 2026 per KPRX's latest filing, from -$47127.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $105715.0 in Q3 2023 and bottomed at -$93557.0 in Q2 2025.
• Historically, Other Non Operating Income has averaged -$11416.6 across 5 years, with a median of -$19253.5 in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 11182.28% in 2023, then tumbled 396.03% in 2025.
• Over 5 years, Other Non Operating Income stood at -$19646.0 in 2022, then tumbled by 234.17% to -$65652.0 in 2023, then surged by 247.44% to $96797.0 in 2024, then tumbled by 127.64% to -$26755.0 in 2025, then jumped by 57.13% to -$11471.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$11471.0, -$47127.0, and -$26755.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.